Literature DB >> 17698003

Crystal structure of human nicotinamide riboside kinase.

Javed A Khan1, Song Xiang, Liang Tong.   

Abstract

Nicotinamide riboside kinase (NRK) has an important role in the biosynthesis of NAD(+) as well as the activation of tiazofurin and other NR analogs for anticancer therapy. NRK belongs to the deoxynucleoside kinase and nucleoside monophosphate (NMP) kinase superfamily, although the degree of sequence conservation is very low. We report here the crystal structures of human NRK1 in a binary complex with the reaction product nicotinamide mononucleotide (NMN) at 1.5 A resolution and in a ternary complex with ADP and tiazofurin at 2.7 A resolution. The active site is located in a groove between the central parallel beta sheet core and the LID and NMP-binding domains. The hydroxyl groups on the ribose of NR are recognized by Asp56 and Arg129, and Asp36 is the general base of the enzyme. Mutation of residues in the active site can abolish the catalytic activity of the enzyme, confirming the structural observations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698003     DOI: 10.1016/j.str.2007.06.017

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  11 in total

Review 1.  Novel avenues of drug discovery and biomarkers for diabetes mellitus.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  J Clin Pharmacol       Date:  2010-03-10       Impact factor: 3.126

2.  Diabetes mellitus: channeling care through cellular discovery.

Authors:  Kenneth Maiese; Yan Chen Shang; Zhao Zhong Chong; Jinling Hou
Journal:  Curr Neurovasc Res       Date:  2010-02       Impact factor: 1.990

3.  Chemoenzymatic Preparation of 4'-Thioribose NAD.

Authors:  Xiao-Nan Zhang; Zhefu Dai; Qinqin Cheng; Yong Zhang
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2019-04-05

4.  Structure of a tRNA-dependent kinase essential for selenocysteine decoding.

Authors:  Yuhei Araiso; R Lynn Sherrer; Ryuichiro Ishitani; Joanne M L Ho; Dieter Söll; Osamu Nureki
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-10       Impact factor: 11.205

5.  Novel synthetic route to the C-nucleoside, 2-deoxy benzamide riboside.

Authors:  Rebecca R Midtkandal; Philip Redpath; Samuel A J Trammell; Simon J F Macdonald; Charles Brenner; Marie E Migaud
Journal:  Bioorg Med Chem Lett       Date:  2012-06-28       Impact factor: 2.823

Review 6.  New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.

Authors:  Kenneth Maiese
Journal:  Front Biosci (Landmark Ed)       Date:  2020-06-01

7.  New function for Escherichia coli xanthosine phophorylase (xapA): genetic and biochemical evidences on its participation in NAD(+) salvage from nicotinamide.

Authors:  Wei-Ren Dong; Cen-Cen Sun; Guan Zhu; Shi-Hua Hu; Li-Xin Xiang; Jian-Zhong Shao
Journal:  BMC Microbiol       Date:  2014-02-08       Impact factor: 3.605

8.  A ribose-functionalized NAD+ with unexpected high activity and selectivity for protein poly-ADP-ribosylation.

Authors:  Xiao-Nan Zhang; Qinqin Cheng; Jingwen Chen; Albert T Lam; Yanran Lu; Zhefu Dai; Hua Pei; Nikolai M Evdokimov; Stan G Louie; Yong Zhang
Journal:  Nat Commun       Date:  2019-09-13       Impact factor: 14.919

Review 9.  The vitamin nicotinamide: translating nutrition into clinical care.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Molecules       Date:  2009-09-09       Impact factor: 4.411

Review 10.  Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2021       Impact factor: 1.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.